WALTHAM, Mass., Sept. 23, 2024 /PRNewswire/ — Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a proprietary platform pioneering a shift to rationally designed therapies for devastating, rare, and prevalent diseases, today announced that Rick Modi, Affinia’s…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.